thymidine 5'-triphosphate has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabezas-Herrera, J; Chazarra, S; Fernández-Pérez, MP; Freter, R; Goding, CR; Middleton, M; Montenegro, MF; Piñero-Madrona, A; Rodríguez-López, JN; Sáez-Ayala, M; Sánchez-Del-Campo, L | 1 |
| Cabezas-Herrera, J; Chazarra, S; Fernández-Pérez, MP; Montenegro, MF; Piñero-Madrona, A; Rodríguez-López, JN; Sáez-Ayala, M; Sánchez-del-Campo, L | 1 |
| Appel, H; Leyva, A; Pinedo, HM | 1 |
3 other study(ies) available for thymidine 5'-triphosphate and Malignant Melanoma
| Article | Year |
|---|---|
Directed phenotype switching as an effective antimelanoma strategy.
Topics: Apoptosis; Catechin; Cell Differentiation; Cell Line, Tumor; DNA Damage; E2F1 Transcription Factor; Humans; Melanoma; Methotrexate; Microphthalmia-Associated Transcription Factor; Phenotype; Thymine Nucleotides | 2013 |
Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance.
Topics: Amino Acid Sequence; Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Checkpoint Kinase 1; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Enzyme Activation; Folic Acid; Humans; Melanoma; Methotrexate; Mice; Molecular Sequence Data; Protein Kinases; Protein Processing, Post-Translational; S Phase Cell Cycle Checkpoints; Skin Neoplasms; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Thymine Nucleotides; Transcription, Genetic | 2012 |
Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
Topics: B-Lymphocytes; Cell Line; Deoxycytosine Nucleotides; Deoxyguanine Nucleotides; Deoxyribonucleotides; Humans; Melanoma; T-Lymphocytes; Thymidine; Thymine Nucleotides | 1984 |